Emedastine is a second generation antihistamine used in eye drops to alleviate the symptoms of allergic conjunctivitis. It acts as a H₁ receptor antagonist. It works by blocking the action of histamine that causes allergic symptoms. It is used in form of + some more technical info: typically administered as the difumarate salt in ophthalmic solution at 0.05% w/v, formulated for topical ocular delivery with pH adjustment and isotonicity appropriate for the ocular surface. The molecule contains an aminobenzoxazole pharmacophore that confers high H1 receptor affinity and low systemic bioavailability after topical application. Pharmacologically it produces a rapid onset of symptom relief by competitively inhibiting histamine binding to H1 receptors on conjunctival blood vessels and sensory nerve endings, reducing vasodilation, vascular permeability and pruritus. Typical formulation controls include assay by HPLC, particulate and sterility specifications for sterile presentations, and stability data for shelf life and in-use periods.
Parent: Emedastine / Emedastine Difumarate
Typical quality control limits for emedastine difumarate API and ophthalmic products set assay acceptance near 98.0 to 102.0% and limit total impurities to 0.50% or less while individual unspecified impurities are commonly limited to 0.10 to 0.20% depending on regulatory monograph or company specification. Known related compounds and process related substances that are monitored include potential N-dealkylated or desmethyl derivatives, N-oxide species, and hydroxylated degradation products; these are routinely controlled to ≤0.10% individually where identified and to a combined limit consistent with the total impurity specification. Residual solvents are managed per ICH Q3C class limits, heavy metals are controlled to typical pharmacopeial limits, and final sterile ophthalmic products must meet microbial/sterility acceptance criteria and endotoxin specifications. Identification and quantitation are performed by validated HPLC and LC-MS methods with forced degradation studies used to characterize degradants.
Emedastine eye drops are used to relieve ocular itching, redness and related signs of allergic conjunctivitis by blocking H1 receptor mediated effects of histamine on the conjunctiva.
Emedastine is a selective H1 receptor antagonist that competitively inhibits histamine binding at H1 receptors in ocular tissues, reducing histamine induced vasodilation, increased vascular permeability and sensory nerve activation; formulation properties limit systemic exposure.
The generic name is emedastine; for ophthalmic use it is commonly supplied as emedastine difumarate.
Ketotifen is an antihistamine with mast cell stabilizing activity used topically in the eye to prevent and treat allergic conjunctivitis symptoms such as itching and redness. Systemic formulations are used for certain allergic conditions as prescribed.
